4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-019028
Chief Operating Officer acquired 2,671 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prince Joshua S. Chief Operating Officer | 2024-06-28 | Grant or award | +2,671 | $2.96 | $7,901 | 2,671 | D |
Loading xslF345X05/form4-07022024_100701.xml…